Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Diltiazem vs Nitroglycerin for Scleroderma Digital Ulcers
NCT02801305Phase 2Completed
- Start
- Jun 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of DOLIZEM in Digital ulcer (3 arms). Primary endpoint: Healing process of scleroderma digital ulcers at 10 months. Started Jun 2016; status: completed.
02
Drugs
DOLIZEM
03
Conditions
Digital ulcer
Beyond the preview
Go deeper on NCT02801305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02801305.